Clinical experience with Uralyt-U used in patients with gout and nephrolithiasis

Clinical experience with Uralyt-U used in patients with gout and nephrolithiasis

Show other versions (1)

The impact of a 4-week course of therapy with Uralyt-U (potassium-sodium hydrocitrate) on uric acid (UA) metabolic parameters was studied in patients with gout and nephrolithiasis. Elevated daily urinary excretion of UA was found to be directly correlated with its lower serum level after 4-week ther...

Full description

Bibliographic Details
Main Authors:	M S Eliseyev, I S Denisov, Viktoria Georgiyevna Barskova
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2012-03-01
Series:	Современная ревматология
Subjects:	gout urate nephrolithiasis hyperuricemia
Online Access:	http://mrj.ima-press.net/index.php/mrj/article/view/400

Similar Items

Experience with Uralyt-U citralite used in patients with gout and nephrolithiasis
by: Maksim Sergeyevich Eliseyev, et al.
Published: (2012-09-01)

Clinical experience with Uralyt-U used in patients with gout and nephrolithiasis
by: M S Eliseyev, et al.
Published: (2012-03-01)

Current ideas on the pathogenesis of uric acid nephrolithiasis and its correction methods in gouty patients
by: V G Barskova, et al.
Published: (2011-12-01)

Experience with Uralyt-U citralite used in patients with gout and nephrolithiasis
by: Maksim Sergeyevich Eliseyev, et al.
Published: (2012-09-01)

Uric acid transporter inhibitors for gout
by: Philip K. Tan, et al.
Published: (2017-06-01)

The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients
by: Blanka Stiburkova, et al.
Published: (2019-03-01)

Management of gout in the primary care setting
by: Qin Jian Low, et al.
Published: (2022-04-01)

Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout
by: Rebekah Wrigley, et al.
Published: (2020-03-01)

Gout: objective, indications and adherence to uratelowering therapy
by: V. V. Tsurko, et al.
Published: (2019-03-01)

Disorder of purine metabolism in the etiopathogenesis of urate nephrolithiasis
by: S. I. Vorotyntsev, et al.
Published: (2023-04-01)

Nephrolithiasis in gout: prevalence and characteristics of Brazilian patients
by: Leonardo Santos Hoff, et al.
Published: (2019-12-01)

GOUT OUTCOMES. LITERATURE REVIEW. PART II. COMORBID DISEASES, RISK OF DEVELOPING CARDIOVASCULAR CATASTROPHES AND DEATH IN GOUT PATIENTS
by: Igor Sergeevich Denisov, et al.
Published: (2014-02-01)

The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout—An Update
by: Robert Eckenstaler, et al.
Published: (2021-06-01)

Modern paradigm of treatment of hyperuricemia and gout in comorbid patients with the development of cardio-vascular pathology
by: V. I. Mazurov, et al.
Published: (2020-12-01)

Incidence of and risk factors for nephrolithiasis in patients with gout and the general population, a cohort study
by: A. J. Landgren, et al.
Published: (2017-07-01)

GOUT OUTCOMES. A REVIEW OF LITERATURE. PART 1. GOUT: EPIDEMIOLOGY, RISK FACTORS, COURSE OF THE DISEASE WITH THE DEVELOPMENT OF CHRONIC TOPHUS FORM
by: Igor Sergeyevich Denisov, et al.
Published: (2013-12-01)

Decrease in Serum Urate Level Is Associated With Loss of Visceral Fat in Male Gout Patients
by: Zijing Ran, et al.
Published: (2021-09-01)

Two cases of acute urate nephropathy in women with asymptomatic hyperuricemia
by: L. N. Yeliseyeva, et al.
Published: (2021-03-01)

Seasonal variations for newly prescribed urate-lowering drugs for asymptomatic hyperuricemia and gout in Japan
by: Masafumi Kurajoh, et al.
Published: (2024-01-01)

Why Does Hyperuricemia Not Necessarily Induce Gout?
by: Wei-Zheng Zhang
Published: (2021-02-01)

Febuxostat as an effective drug of choice for urate-lowering therapy for gout (case report)
by: A. B. Bashkova, et al.
Published: (2022-08-01)

Uric acid-lowering effect of dotinurad, a novel selective urate reabsorption inhibitor, in hypertensive patients with gout or asymptomatic hyperuricemia: a pooled analysis of individual participant data in phase II and III trials
by: Toshinari Takahashi, et al.
Published: (2021-11-01)

COMBINED TREATMENT FOR DENDRITIC NEPHROLITHIASIS. CLINICAL CASE
by: V. L. Medvedev, et al.
Published: (2019-03-01)

COMBINED TREATMENT FOR DENDRITIC NEPHROLITHIASIS. CLINICAL CASE
by: V. L. Medvedev, et al.
Published: (2019-03-01)

Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment
by: Aleš Kvasnička, et al.
Published: (2023-12-01)

Functional Characterization of Rare Variants in OAT1/<i>SLC22A6</i> and OAT3/<i>SLC22A8</i> Urate Transporters Identified in a Gout and Hyperuricemia Cohort
by: Jiří Vávra, et al.
Published: (2022-03-01)

ULTRASONOGRAPHIC CHANGES IN THE HYALINE CARTILAGE: EVALUATION OF SENSITIVITY AND SPECIFICITY IN EARLY GOUTY ARTHRITIS
by: A. V. Petrov, et al.
Published: (2017-07-01)

Assessment of the quality of life indicators in patients with urate nephrolithiasis comorbid with metabolic syndrome
by: S. I. Bilai
Published: (2022-04-01)

Uricase-Deficient Larval Zebrafish with Elevated Urate Levels Demonstrate Suppressed Acute Inflammatory Response to Monosodium Urate Crystals and Prolonged Crystal Persistence
by: Tanja Linnerz, et al.
Published: (2022-11-01)

The Occurrence of Nephrolithiasis in Gout Patients: A Longitudinal Follow-Up Study Using a National Health Screening Cohort
by: So Young Kim, et al.
Published: (2022-04-01)

Treatment of Gout in Patients with CrCl ≤30 mL/min and/or on Hemodialysis: A Review
by: Fares Saliba, et al.
Published: (2024-03-01)

Interactions between serum urate-associated genetic variants and sex on gout risk: analysis of the UK Biobank
by: Ravi K. Narang, et al.
Published: (2019-01-01)

Initiating guideline-concordant gout treatment improves arterial endothelial function and reduces intercritical inflammation: a prospective observational study
by: Michael Toprover, et al.
Published: (2020-07-01)

The Association between Serum Testosterone and Hyperuricemia in Males
by: Meng-Ko Tsai, et al.
Published: (2022-05-01)

Discovery of Novel Biphenyl Carboxylic Acid Derivatives as Potent URAT1 Inhibitors
by: Xianxin Hou, et al.
Published: (2023-11-01)

NEW INTERNATIONAL RECOMMENDATIONS FOR THE DIAGNOSIS AND TREATMENT OF GOUT
by: M. S. Eliseev
Published: (2014-06-01)

Magnetic resonance spectroscopy in the management of tophaceous gout: A case report
by: Patricia Khashayar, et al.
Published: (2015-01-01)

Prevention of arthritis attacks in the use of urate-lowering therapy in patients with gout
by: M. N. Chikina
Published: (2019-01-01)

Prospects of anti-inflammatory and urate-lowering therapy of gout: A vector from the past to the future
by: A. A. Garanin, et al.
Published: (2022-05-01)

«URAT-INDEX» – NON-INVASIVE TOOL FOR PREDICTION OF URIC ACID CONTAINING STONES
by: N. K. Gadzhiev, et al.
Published: (2018-01-01)